Piper Sandler Maintains Overweight on Organon, Raises Price Target to $24

Organon & Co. Common Stock +0.05%

Organon & Co. Common Stock

OGN

20.98

+0.05%

Piper Sandler analyst David Amsellem maintains Organon (NYSE: OGN) with a Overweight and raises the price target from $22 to $24.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via